切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2022, Vol. 15 ›› Issue (06) : 448 -453. doi: 10.3877/cma.j.issn.1674-6880.2022.06.002

论著

艾司洛尔对脓毒症大鼠急性心肌损伤的保护作用
刘茂霞1, 张艳兵2, 李正达1, 金钧1, 杨新静1,()   
  1. 1. 215100 江苏苏州,苏州大学附属第一医院重症医学科
    2. 215100 江苏苏州,苏州大学附属第一医院麻醉科
  • 收稿日期:2022-08-14 出版日期:2022-12-31
  • 通信作者: 杨新静
  • 基金资助:
    中华国际医学交流基金会心血管多学科整合思维研究基金项目(Z-2016-23-2001-46)

Protective effect of esmolol on sepsis-induced acute myocardial injury in rats

Maoxia Liu1, Yanbing Zhang2, Zhengda Li1, Jun Jin1, Xinjing Yang1,()   

  1. 1. Department of Intensive Care Unit, First Affiliated Hospital of Soochow University, Suzhou 215100, China
    2. Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou 215100, China
  • Received:2022-08-14 Published:2022-12-31
  • Corresponding author: Xinjing Yang
引用本文:

刘茂霞, 张艳兵, 李正达, 金钧, 杨新静. 艾司洛尔对脓毒症大鼠急性心肌损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2022, 15(06): 448-453.

Maoxia Liu, Yanbing Zhang, Zhengda Li, Jun Jin, Xinjing Yang. Protective effect of esmolol on sepsis-induced acute myocardial injury in rats[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2022, 15(06): 448-453.

目的

探讨艾司洛尔对脓毒症大鼠急性心肌损伤的保护作用及其作用机制。

方法

将26只成年雄性Sprague-Dawley大鼠按随机数字表法分为假手术组(6只)、模型组(10只)和艾司洛尔组(10只),各组分别保证6只大鼠进行后续实验分析。艾司洛尔组大鼠持续经左颈内静脉泵入艾司洛尔注射液(15 mg·kg-1·h-1);假手术组、模型组持续泵入等量等渗NaCl溶液。注射30 min后模型组和艾司洛尔组大鼠采用腹腔注射脂多糖(10 mg/kg)建立脓毒症急性心肌损伤模型;假手术组注射等量等渗NaCl溶液。模型构建成功24 h后,观察各组大鼠死亡情况;腹主动脉采血,检测血清心肌肌钙蛋白I(cTnI)水平;取血后处死大鼠,取心脏组织行苏木素-伊红染色,光镜下观察心脏组织病理学变化,并采用Western-blotting检测Beclin-1、微管相关蛋白1轻链3-Ⅱ(LC3-Ⅱ)及Parkin蛋白的表达水平。

结果

建模后24 h假手术组大鼠无死亡,模型组大鼠死亡4只,艾司洛尔组大鼠死亡2只。光镜下,假手术组大鼠心肌组织结构完整,心肌纤维排列有序,心肌细胞形态正常;模型组大鼠心肌纤维紊乱,炎症细胞浸润,细胞肿胀明显,组织坏死;艾司洛尔组大鼠心肌纤维较规则,炎症细胞浸润减少,心肌细胞肿胀好转。3组大鼠间血清cTnI、Beclin-1、LC3-Ⅱ及Parkin蛋白表达水平比较,差异均有统计学意义(F=17.300、110.000、57.670、14.980;P均<0.001)。与模型组大鼠比较,假手术组及艾司洛尔组大鼠血清cTnI均明显降低[(3.2 ± 0.8)、(1.4 ± 0.6)、(1.4 ± 0.7)ng/L],Beclin-1[(0.21 ± 0.07)、(1.01 ± 0.13)、(0.98 ± 0.11)]、LC3-Ⅱ[(0.29 ± 0.11)、(1.02 ± 0.16)、(0.99 ± 0.13)]及Parkin[(0.73 ± 0.09)、(1.00 ± 0.13)、(1.13 ± 0.16)]蛋白表达水平均明显升高(P均<0.05)。

结论

艾司洛尔对脓毒症大鼠急性心肌损伤有显著的保护作用,其具体机制与促进Parkin介导的线粒体自噬有关。

Objective

To investigate the protective effect and specific mechanism of esmolol on sepsis-induced acute cardiac injury in rats.

Methods

A total of 26 adult male Sprague-Dawley rats were randomly divided into the sham group (6 rats), sepsis group (10 rats) and esmolol group (10 rats), and 6 rats in each group were guaranteed for follow-up experimental analysis. In the esmolol group, esmolol (15 mg·kg-1·h-1) was continuously pumped through the left internal jugular vein, and the same amount of isotonic NaCl solution was continuously pumped into the sham group and sepsis group. After 30 min of injection, the sepsis-induced acute cardiac injury model was reproduced by intraperitoneal injection of lipopolysaccharide (10 mg/kg) in the sepsis group and esmolol group, and rats in the sham group only received an equivalent amount of isotonic NaCl solution. The death of rats in each group was observed at 24 h after modeling, and the abdominal aorta blood was collected to test the serum cardiac troponin I (cTnI). The rats were sacrificed after blood collection. The cardiac tissues were collected to observe the pathological structure changes under the hematoxylin-eosin staining by light microscope, and the expression levels of Beclin-1, microtubule-associated protein 1 light 3-Ⅱ (LC3-Ⅱ) and Parkin proteins were tested by Western-blotting.

Results

There were no deaths in the sham group, 4 in the sepsis group and 2 in the esmolol group at 24 h after modeling. Under light microscope, in the sham group, the myocardium structure was complete, the myocardium fibers were arranged in order, and the morphology of myocardium cells was normal; in the sepsis group, myocardial fibers were disordered, inflammatory cells infiltrated, cell swelling was obvious, and tissue necrosis was observed; in the esmolol group, the myocardial fibers were relatively regular, the infiltration of inflammatory cells reduced, and the swelling of myocardial cells improved. The levels of cTnI, Beclin-1, LC3-Ⅱ and Parkin proteins among the three groups all showed significant differences (F = 17.300, 110.00, 57.670, 14.980; all P < 0.001). Compared with the sepsis group, the level of cTnI was much lower [(3.2 ± 0.8), (1.4 ± 0.6), (1.4 ± 0.7) ng/L], and the levels of Beclin-1 [(0.21 ± 0.07), (1.01 ± 0.13), (0.98 ± 0.11)], LC3-Ⅱ [(0.29 ± 0.11), (1.02 ± 0.16), (0.99 ± 0.13)] and Parkin [(0.73 ± 0.09), (1.00 ± 0.13), (1.13 ± 0.16)] proteins were much higher in the sham group and esmolol group (all P < 0.05).

Conclusion

Esmolol has a significant protective effect on acute myocardial injury in sepsis rats, and its mechanism is related to the promotion of Parkin-mediated mitochondrial autophagy.

图1 光镜下各组大鼠心脏组织病理学变化注:a图为假手术组,可见心脏组织结构完整;b图为模型组,可见心肌纤维紊乱,炎症细胞浸润,心肌细胞变性坏死,间质水肿,部分心肌纤维断裂,伴有心肌间质纤维化;c图为艾司洛尔组,心肌纤维较规则,炎症细胞浸润减少,少量心肌细胞变性坏死,间质水肿及心肌间质纤维化减轻(HE染色 × 400)
表1 各组大鼠血清cTnI水平的比较(ng/L, ± s
表2 各组大鼠心脏组织Beclin-1、LC3-Ⅱ及Parkin的蛋白表达比较( ± s
1
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Crit Care Med, 2021, 49 (11): e1063-e1143.
2
Zanotti-Cavazzoni SL, Hollenberg SM. Cardiac dysfunction in severe sepsis and septic shock[J]. Curr Opin Crit Care, 2009, 15 (5): 392-397.
3
Landesberg G, Gilon D, Meroz Y, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock[J]. Eur Heart J, 2012, 33 (7): 895-903.
4
Herndon DN, Hart DW, Wolf SE, et al. Reversal of catabolism by beta-blockade after severe burns[J]. N Engl J Med, 2001, 345 (17): 1223-1229.
5
Suzuki T, Inoue K, Igarashi T, et al. Beta-blocker therapy preserves normal splenic T-lymphocyte numbers reduced in proportion to sepsis severity in a sepsis model[J]. Crit Care Res Pract, 2019: 8157482.
6
Levy B, Fritz C, Piona C, et al. Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study[J]. Crit Care, 2021, 25 (1): 21.
7
Narendra D, Tanaka A, Suen DF, et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy[J]. J Cell Biol, 2008, 183 (5): 795-803.
8
Narendra DP, Jin SM, Tanaka A, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin[J]. PLoS Biol, 2010, 8 (1): e1000298.
9
Hasegawa D, Sato R, Prasitlumkum N, et al. Effect of ultrashort-acting β-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials[J]. Chest, 2021, 159 (6): 2289-2300.
10
Wei C, Louis H, Schmitt M, et al. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock[J]. Crit Care, 2016, 20 (1):407.
11
刘新强,温妙云,李旭声,等. β1受体阻滞剂通过TLR4/NF-κB信号通路抑制脓毒症心肌炎症反应[J].中华危重病急救医学201931(2):193-197.
12
郭玉红,刘清泉.脓毒症心肌功能障碍的研究进展[J].中华急诊医学杂志201726(3):361-366.
13
Hamzaoui O, Teboul JL. The role of beta-blockers in septic patients[J]. Minerva Anestesiol, 2015, 81 (3): 312-319.
14
董小荣,方德舟,张蓓,等.早期应用艾司洛尔对脓毒症大鼠心肌损伤的实验研究[J].兰州大学学报(医学版)201844(4):33-39.
15
Lautz AJ, Zingarelli B. Age-dependent myocardial dysfunction in critically ill patients: role of mitochondrial dysfunction[J]. Int J Mol Sci, 2019, 20 (14): 3523.
16
周密,张琼,王强,等.远端肢体缺血后处理通过线粒体自噬减轻大鼠局灶型脑缺血再灌注损伤的研究[J/CD].中华危重症医学杂志(电子版)202013(4):241-246.
17
Tsubouchi K, Araya J, Kuwano K. PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses[J]. Inflamm Regen, 2018 (38): 18.
18
Shires SE, Gustafsson AB. Regulating renewable energy: connecting ampkα2 to pink1 / parkin-mediated mitophagy in the heart[J]. Circ Res, 2018, 122 (5): 649-651.
19
Shibutani ST, Saitoh T, Nowag H, et al. Autophagy and autophagy-related proteins in the immune system[J]. Nat Immunol, 2015, 16 (10): 1014-1024.
20
刘颖,孟超,赵谊,等.自噬蛋白Beclin1及炎症因子表达在脓毒症急性肾损伤中的作用[J/CD].中华危重症医学杂志(电子版)202013(6):401-405.
21
李小静,李志锋,李显平,等.丹参酮IIA体外促进黑素瘤A375细胞自噬及信号通路的实验研究[J].中华皮肤科杂志201750(1):29-32.
22
Sun Y, Cai Y, Zang QS. Cardiac autophagy in sepsis[J]. Cells, 2019, 8 (2): 141.
23
Sun Y, Yao X, Zhang QJ, et al. Beclin-1-dependent autophagy protects the heart during sepsis[J]. Circulation, 2018, 138 (20): 2247-2262.
24
江木秀,姜春明.线粒体自噬对脓毒症心肌的影响及信号转导途径研究进展[J].国际儿科学杂志202047(7):477-480.
25
Mao JY, Su LX, Li DK, et al. The effects of UCP2 on autophagy through the AMPK signaling pathway in septic cardiomyopathy and the underlying mechanism[J]. Ann Transl Med, 2021, 9 (3): 259.
26
Kimmoun A, Louis H, Al Kattani N, et al. β1-adrenergic inhibition improves cardiac and vascular function in experimental septic shock[J]. Crit Care Med, 2015, 43 (9): e332-e340.
27
洪澄英,陈怀生,曹静,等. β受体拮抗剂对脓毒症大鼠心肌细胞线粒体损伤的保护作用[J].中国医科大学学报201847(12):1123-1127.
[1] 刘思锐, 赵辰阳, 张睿, 张一休, 杨萌. 多普勒超声对孕鼠子宫动脉不同节段血流动力学参数的评估[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 877-883.
[2] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[3] 杨瑾, 刘雪克, 张媛媛, 金钧, 韦瑶. 肠道微生物来源石胆酸对脓毒症相关肝损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 265-274.
[4] 张霞, 张瑞, 郑志波, 张勤. 紫草素调控乳酸化修饰和线粒体功能改善脓毒症心肌病小鼠的预后[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 275-284.
[5] 张婧琦, 江洋, 孙佳璐, 唐兴喆, 赵宇飞, 崔颖, 李信响, 戴景月, 傅琳, 彭新桂. 基于肾周CT特征结合血清肌酐水平探讨脓毒症伴急性肾损伤的早期识别[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 285-292.
[6] 李振翮, 魏长青, 甄国栋, 李振富. 脓毒症并发急性呼吸窘迫综合征患者血清S1P、Wnt5a变化及其临床意义[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 293-300.
[7] 林琳, 田思萌, 于永华, 徐飞飞, 黄明莉. 干细胞及其外泌体治疗宫腔黏连的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 271-275.
[8] 刘锦程, 王斌, 张雯, 张明周, 刘禹, 叶东樊, 黄赞胜, 邱凌霄, 卿斌, 王创业, 王南博, 王苹, 郭宇航, 周培花, 程秋霞, 徐智. 肺泡灌洗液RASSF1A及SHOX2甲基化联合径向超声特征对肺结节性质鉴别诊断的意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 505-511.
[9] 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识编写组. 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 313-324.
[10] 陈曦, 吴宗盛, 郑明珠, 邱海波. 胸腺萎缩在脓毒症免疫紊乱中的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 379-383.
[11] 杨翔, 郭兰骐, 谢剑锋, 邱海波. 转录组学在脓毒症诊疗中的临床研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 384-388.
[12] 胡梓菡, 彭菲, 孙骎, 杨毅. 细胞外囊泡在脓毒症血管内皮损伤作用中的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 265-270.
[13] 陈惠英, 邱敏珊, 邵汉权. 脓毒症诱发肠黏膜屏障功能损伤的风险因素模型构建与应用效果[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 448-452.
[14] 傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.
[15] 席静妮, 李娜, 张琪. 中性粒细胞与淋巴细胞比值对老年重症社区获得性肺炎进展为脓毒症的预测价值[J/OL]. 中华老年病研究电子杂志, 2024, 11(03): 28-31.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?